CD8A and lung cancer: In lung cancer, this immune excluded phenotype could be partly restored by remodeling of the tumor-surrounding ECM by treatment with collagenase D. Similarly, chemically targeting the ECM production by CAFs in murine models of lung cancer and melanoma also resulted in enhanced CD8+ infiltration [77].